Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $490.86 | 25 | 95.7% |
| Education | $22.31 | 2 | 4.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $409.30 | 20 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $43.03 | 2 | $0 (2017) |
| AMAG Pharmaceuticals, Inc. | $22.31 | 2 | $0 (2017) |
| Seattle Genetics, Inc. | $14.00 | 1 | $0 (2017) |
| Millennium Pharmaceuticals, Inc. | $13.55 | 1 | $0 (2017) |
| Incyte Corporation | $10.98 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2018 | $199.87 | 10 | Novartis Pharmaceuticals Corporation ($199.87) |
| 2017 | $313.30 | 17 | Novartis Pharmaceuticals Corporation ($209.43) |
All Payment Transactions
27 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2018 | Novartis Pharmaceuticals Corporation | JADENU (Drug), PROMACTA | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: HEMATOLOGY | ||||||
| 11/07/2018 | Novartis Pharmaceuticals Corporation | TASIGNA (Drug) | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: ONCOLOGY | ||||||
| 09/05/2018 | Novartis Pharmaceuticals Corporation | TASIGNA (Drug) | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: ONCOLOGY | ||||||
| 08/01/2018 | Novartis Pharmaceuticals Corporation | TASIGNA (Drug) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: ONCOLOGY | ||||||
| 06/06/2018 | Novartis Pharmaceuticals Corporation | TASIGNA (Drug) | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: ONCOLOGY | ||||||
| 05/02/2018 | Novartis Pharmaceuticals Corporation | TASIGNA (Drug) | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: ONCOLOGY | ||||||
| 04/04/2018 | Novartis Pharmaceuticals Corporation | TASIGNA (Drug) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: ONCOLOGY | ||||||
| 03/07/2018 | Novartis Pharmaceuticals Corporation | TASIGNA (Drug) | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: ONCOLOGY | ||||||
| 02/07/2018 | Novartis Pharmaceuticals Corporation | TASIGNA (Drug) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: ONCOLOGY | ||||||
| 01/03/2018 | Novartis Pharmaceuticals Corporation | TASIGNA (Drug) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: ONCOLOGY | ||||||
| 12/06/2017 | Novartis Pharmaceuticals Corporation | TASIGNA (Drug) | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: ONCOLOGY | ||||||
| 11/01/2017 | Novartis Pharmaceuticals Corporation | TASIGNA (Drug) | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: ONCOLOGY | ||||||
| 10/04/2017 | Novartis Pharmaceuticals Corporation | TASIGNA (Drug) | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: ONCOLOGY | ||||||
| 09/27/2017 | Seattle Genetics, Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Not Applicable | ||||||
| 09/20/2017 | Millennium Pharmaceuticals, Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: Oncology | ||||||
| 09/06/2017 | Novartis Pharmaceuticals Corporation | RYDAPT (Drug), TASIGNA | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: HEMATOLOGY | ||||||
| 08/16/2017 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $20.40 | General |
| 08/02/2017 | Novartis Pharmaceuticals Corporation | TASIGNA (Drug) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: ONCOLOGY | ||||||
| 07/05/2017 | Novartis Pharmaceuticals Corporation | TASIGNA (Drug) | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: ONCOLOGY | ||||||
| 06/07/2017 | Novartis Pharmaceuticals Corporation | TASIGNA (Drug) | Food and Beverage | In-kind items and services | $23.51 | General |
| Category: ONCOLOGY | ||||||
| 05/10/2017 | AMAG Pharmaceuticals, Inc. | FERAHEME (Drug) | Education | In-kind items and services | $11.30 | General |
| Category: PARENTERAL IRON REPLACEMENT | ||||||
| 05/03/2017 | Novartis Pharmaceuticals Corporation | TASIGNA (Drug) | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: ONCOLOGY | ||||||
| 04/05/2017 | Novartis Pharmaceuticals Corporation | TASIGNA (Drug) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: ONCOLOGY | ||||||
| 03/15/2017 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $10.98 | General |
| Category: Hematology/Oncology | ||||||
| 03/08/2017 | AMAG Pharmaceuticals, Inc. | FERAHEME (Drug) | Education | In-kind items and services | $11.01 | General |
| Category: PARENTERAL IRON REPLACEMENT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 28 | 35 | $4,301 | $1,220 |
All Medicare Procedures & Services
2 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88189 | Flow cytometry technique for dna or cell analysis, 16 or more markers | Facility | 2023 | 12 | 12 | $2,760 | $822.96 | 29.8% |
| 85060 | Blood smear interpretation by physician with written report | Facility | 2023 | 16 | 23 | $1,541 | $396.80 | 25.7% |
About Dr. Marwan Yared, MD
Dr. Marwan Yared, MD is a Hematology healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1780774273.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marwan Yared, MD has received a total of $513.17 in payments from pharmaceutical and medical device companies, with $199.87 received in 2018. These payments were reported across 27 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($490.86).
As a Medicare-enrolled provider, Yared has provided services to 28 Medicare beneficiaries, totaling 35 services with total Medicare billing of $1,220. Data is available for 1 year (2023–2023), covering 2 distinct procedure/service records.
Practice Information
- Specialty Hematology
- Other Specialties Anatomic Pathology & Clinical Pathology, Hematology
- Location Houston, TX
- Active Since 10/13/2006
- Last Updated 03/21/2024
- Taxonomy Code 207ZH0000X
- Entity Type Individual
- NPI Number 1780774273
Products in Payments
- TASIGNA (Drug) $372.34
- EMPLICITI (Biological) $22.63
- FERAHEME (Drug) $22.31
- RYDAPT (Drug) $20.04
- JADENU (Drug) $16.92
- ADCETRIS (Biological) $14.00
- NINLARO (Drug) $13.55
- JAKAFI (Drug) $10.98
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology Doctors in Houston
Loretta Nastoupil, M.d, M.D
Hematology — Payments: $569,768
Kelty Baker, Md, MD
Hematology — Payments: $301,763
Dr. Siddhartha Ganguly, M.d, M.D
Hematology — Payments: $238,662
Lawrence Rice, M.d, M.D
Hematology — Payments: $88,796
Dr. Modupe Idowu, M.d, M.D
Hematology — Payments: $88,441
Carlos Bueso-Ramos, M.d., Phd, M.D., PHD
Hematology — Payments: $41,524